1. Home
  2. AZN vs TMUS Comparison

AZN vs TMUS Comparison

Compare AZN & TMUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZN
  • TMUS
  • Stock Information
  • Founded
  • AZN 1992
  • TMUS 1994
  • Country
  • AZN United Kingdom
  • TMUS United States
  • Employees
  • AZN N/A
  • TMUS N/A
  • Industry
  • AZN Biotechnology: Pharmaceutical Preparations
  • TMUS Telecommunications Equipment
  • Sector
  • AZN Health Care
  • TMUS Telecommunications
  • Exchange
  • AZN Nasdaq
  • TMUS Nasdaq
  • Market Cap
  • AZN 228.2B
  • TMUS 264.8B
  • IPO Year
  • AZN 1993
  • TMUS N/A
  • Fundamental
  • Price
  • AZN $79.93
  • TMUS $251.99
  • Analyst Decision
  • AZN Strong Buy
  • TMUS Buy
  • Analyst Count
  • AZN 2
  • TMUS 22
  • Target Price
  • AZN N/A
  • TMUS $256.64
  • AVG Volume (30 Days)
  • AZN 3.8M
  • TMUS 3.9M
  • Earning Date
  • AZN 07-29-2025
  • TMUS 10-23-2025
  • Dividend Yield
  • AZN 1.92%
  • TMUS 1.40%
  • EPS Growth
  • AZN 28.86
  • TMUS 32.79
  • EPS
  • AZN 5.31
  • TMUS 10.59
  • Revenue
  • AZN $56,501,000,000.00
  • TMUS $84,052,000,000.00
  • Revenue This Year
  • AZN $10.57
  • TMUS $8.80
  • Revenue Next Year
  • AZN $6.25
  • TMUS $5.42
  • P/E Ratio
  • AZN $29.77
  • TMUS $23.79
  • Revenue Growth
  • AZN 15.00
  • TMUS 6.27
  • 52 Week Low
  • AZN $61.24
  • TMUS $192.61
  • 52 Week High
  • AZN $87.68
  • TMUS $276.49
  • Technical
  • Relative Strength Index (RSI)
  • AZN 62.38
  • TMUS 57.63
  • Support Level
  • AZN $79.35
  • TMUS $249.42
  • Resistance Level
  • AZN $81.56
  • TMUS $252.27
  • Average True Range (ATR)
  • AZN 0.95
  • TMUS 3.90
  • MACD
  • AZN -0.05
  • TMUS -0.74
  • Stochastic Oscillator
  • AZN 73.01
  • TMUS 27.83

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

About TMUS T-Mobile US Inc.

Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 80 million postpaid and 25 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.

Share on Social Networks: